Data from a multinational, hospital-based, case-control study were analyzed to determine whether use of combined oral contraceptives (OC) around the time of menopause preferentially increases risk of breast cancer. Results show that the relative risk (RR) of breast cancer was increased in women of a
Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa)
β Scribed by Samuel Shapiro; Lynn Rosenberg; Margaret Hoffman; Judith P. Kelly; Diane D. Cooper; Henri Carrara; Lynnette E. Denny; George du Toit; Bruce R. Allan; Ilse A. Stander; Anna-Lise Williamson
- Book ID
- 111546181
- Publisher
- Springer Netherlands
- Year
- 2003
- Tongue
- English
- Weight
- 110 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Female residents of six counties in Washington and Utah in whom a diagnosis of ovarian cancer was made during 1975β79 were interviewed concerning prior use of oral contraceptives. Interviews with a random sample of women drawn from these same counties were obtained for comparison. A sma
## Abstract The relationship between the strength of the estrogenic and progestational components of combined oral contraceptives and risk of endometrial carcinoma was examined in a multinational hospitalβbased caseβcontrol study comparing 220 cases from 7 countries with 1,537 ageβ and hospitalβmat